首页|冷冻治疗应用于宫颈长期高危型HPV感染的疗效观察

冷冻治疗应用于宫颈长期高危型HPV感染的疗效观察

扫码查看
目的 探讨冷冻治疗应用于宫颈长期高危型人乳头瘤病毒(HPV)感染的治疗效果。方法 选取2021年6月至2022年6月上海市中西医结合医院妇科门诊就诊的80例高危型HPV感染患者作为研究对象,采用抽签法分为冷冻组、干扰素组,每组各40例。冷冻组进行宫颈冷冻治疗,干扰素组进行干扰素治疗。观察随访6个月后两组患者的HPV、宫颈液基薄层细胞学检查(TCT)及宫颈多点活检病理结果。结果 观察6个月后,冷冻组患者的HPV转阴情况优于干扰素组,差异有统计学意义(P<0。05);两组的TCT结果比较,差异无统计学意义(P>0。05);冷冻组的宫颈活检病理情况优于干扰素组,差异有统计学意义(P<0。05)。结论 冷冻治疗对宫颈长期高危型HPV感染的治疗效果优于干扰素,改善HPV转阴情况,同时对于宫颈鳞状上皮内低度病变有较好的疗效。
Effect observation of cryotherapy on long-term high-risk HPV infection of cervix
Objective To investigate the effect of cryotherapy on long-term high-risk human papillomavirus(HPV)infec-tion of the cervix.Methods A total of 80 patients with high-risk HPV infection who were treated in the gynecological clinic of Shanghai Integrated Traditional Chinese and Western Medicine Hospital from June 2021 to June 2022 were selected as the research objects.They were divided into cryotherapy group and interferon group by lottery method,with 40 cases in each group.The results of HPV,cervical thin-prep cytology test(TCT)and cervical multi-point biopsy were observed after 6 months of follow-up.Results After 6 months of observation,the negative conversion of HPV in the cryotherapy group was better than that in the interferon group,and the difference was statistically significant(P<0.05).There was no significant difference in TCT result between the two groups(P>0.05).The pathological result of cervical biopsy in the cryotherapy group was better than that in the interferon group,and the difference was statistically significant(P<0.05).Conclusion Cryotherapy is more effective than interferon in the treatment of long-term high-risk HPV infection of the cervix,improving the negative conversion of HPV,and has a better effect on low-grade cervical squamous intraepithelial lesions.

Human papillomavirusCryotherapyRecombinant human interferon α 2b vaginal effervating tabletsCervical intraepithelial lesions

庄楣、曹丽琴、张莲群、来婷

展开 >

上海中医药大学附属上海市中西医结合医院妇科,上海 200082

人乳头瘤病毒 冷冻治疗 重组人干扰素α2b阴道泡腾片 宫颈上皮内病变

上海市虹口区卫生健康委员会医学科研课题

虹卫2002-06

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(2)
  • 26